Chronic Myeloid Leukemia Treatments
32 ta ish
Optimizing ibrutinib bioavailability: Formulation and assessment of hydroxypropyl-β-cyclodextrin-based nanosponge delivery systems
Sunitha Sampathi, Nitiraj Kulkarni, D. V. R. N. Bhikshapathi +4
MaqolaChronic Lymphocytic Leukemia ResearchCurrent Research in Pharmacology and Drug Discovery20250 iqtibosABITHE SIGNIFICANCE OF DRIVER GENE MUTATIONS JAK2, CALR, AND MPL IN CHRONIC MYELOPROLIFERATIVE DISEASES
Beknur Bobir ugli Giyosov, Kodirjon Tukhtaboevich Boboev, Feruz Asatullaevich Daminov
MaqolaMyeloproliferative Neoplasms: Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)20260 iqtibosABI